Dr. Fraser Brown is a partner in the patent counseling and prosecution practice. His practice focuses on biotechnology issues, with particular emphasis on drafting and prosecuting patent applications, and preparing invalidity, freedom to operate and patentability opinions. Fraser has also negotiated agreements to further clients' collaborative research and development strategies. He has counseled clients on a range of technical areas including vaccines, fluorescent proteins, drug design and screening, and cancer therapies.
Prior to joining Cooley in 2012, Fraser was at Banner & Witcoff, Ltd. in their Washington, DC office.
Fraser holds a PhD in biochemistry from the University of Birmingham, England where he researched cell signaling pathways, particularly phospholipases and lipid kinases, associated with immune cells. He also spent seven years performing molecular cell biology research in the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD, where he investigated the regulation and role of GTPases in controlling cell membrane structure using antibody- and live cell imaging-based approaches.
Fraser's research is published in the Journal of Cell Biology and the Journal of Biological Chemistry, among others. He has also published several articles relating to intellectual property issues facing the biotechnology industry.
Georgetown University Law Center
University of Birmingham
University of Glasgow
Admissions & credentials
District of Columbia
Limited Recognition to practice before the United States Patent & Trademark Office (USPTO)
Rankings & accolades
Legal 500: Top Lawyer for Patent Prosecution